HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.

Abstract
Mouse EL-4 lymphoma cells exposed in vitro for short periods to 4-hydroperoxycyclophosphamide, an in vitro active derivative of cyclophosphamide, and to another alkylating agent, cis-diamminedichloroplatinum(II), as well as to mitomycin C, induced development of antitumor immunity in syngeneic mice co-administered with OK-432, an immunostimulator prepared from streptococci. The anthracyclines (adriamycin and daunomycin) were very slightly effective. The efficacy of the alkylating agents in inducing tumor immunity was also demonstrated by their ability to stimulate secondary in vitro generation of splenic cytotoxicity. These data supported the proposed explanation for effectiveness of chemoimmunotherapy against poorly immunogenic tumors.
AuthorsT Ujiie
JournalThe Japanese journal of experimental medicine (Jpn J Exp Med) Vol. 58 Issue 1 Pg. 33-8 (Feb 1988) ISSN: 0021-5031 [Print] Japan
PMID2454340 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Mitomycins
  • Nitrosourea Compounds
  • Nimustine
  • Bleomycin
  • Mitomycin
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • perfosfamide
  • Daunorubicin
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Bleomycin (pharmacology)
  • Cisplatin (pharmacology)
  • Cyclophosphamide (analogs & derivatives, pharmacology)
  • Cytotoxicity, Immunologic
  • Daunorubicin (pharmacology)
  • Doxorubicin (pharmacology)
  • Female
  • Immunity, Innate
  • Immunization
  • Mice
  • Mice, Inbred C57BL
  • Mitomycin
  • Mitomycins (pharmacology)
  • Neoplasm Transplantation
  • Nimustine
  • Nitrosourea Compounds (pharmacology)
  • Spleen (immunology, pathology)
  • Thymoma (immunology, pathology)
  • Tumor Cells, Cultured (drug effects, immunology, transplantation)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: